The specialized neurosurgical expertise of University of Iowa physician-scientists and the generous contributions of UI Health Care neurosurgery patients who volunteer to participate in research were instrumental to new findings that reveal the sequence of brain activity involved when people evaluate risk and reward during decision-making. The study, conducted by researchers at Caltech in…
Research and Education
Research and Education
Theranostics—a pioneering fusion of therapeutic and diagnostic technologies—is redefining the cancer treatment landscape, with University of Iowa Health Care blazing a path forward. “We know that radiation is probably the single most effective agent at treating cancers,” says John Buatti, MD, professor in the Carver College of Medicine Department of Radiation Oncology. “While radiation can…
Drawing on modern culinary techniques, researchers have developed a carbon-monoxide-infused foam that can be applied topically to wounds and improves healing in models of diabetic wounds and pressure ulcers. The results of the study, led by James Byrne, MD, PhD, University of Iowa assistant professor of radiation oncology and biomedical engineering, were published March 12 in Device, a Cell Press…
Another Match Day is in the record books for the UI Carver College of Medicine, with all the excitement, laughter, and happy tears that come with learning where our students will take the next significant step in their careers. This year, 141 medical students will graduate from our college, of which 30% will go on to residency training in Iowa. They matched into 23 different specialties across 30…
Researchers at the University of Iowa and Stanford University have developed a new tool that allows scientists to safely and accurately measure the effect of transcranial magnetic stimulation (TMS) on the activity of deep brain structures. The new technique, known as TMS-iEEG (intracranial electrocorticography), is providing hard data on how TMS works and may lead to improvements in the…
University of Iowa Health Care is among the first sites in the country to participate in a phase 3 clinical trial to test a new, personalized vaccine for patients with high-risk melanoma. The study will combine individualized mRNA vaccines with the immunotherapy pembrolizumab to determine if the combination is safe and does a better job than pembrolizumab alone at preventing melanoma from…
The U.S. Food and Drug Administration (FDA) approved a medical technology created by a University of Iowa faculty member to treat atrial fibrillation (Afib) in January 2024. Now, physicians in the cardiac electrophysiology division of UI Health Care are the first in the state to begin using the technology in clinical care. “Pulse field ablation, particularly Farapulse, offers a safe, more…
Extremely premature infants who were fed donated breast milk had less than half the rate of a life-threatening disease than those fed formula, according to a new study led by the University of Iowa. Researchers also found extremely preterm infants—classified as babies born before 29 weeks—who were fed donor milk experienced the same neurological development as those who were fed formula…
Did smokers do better than non-smokers in a clinical trial for an experimental cancer treatment? That was the intriguing question that led University of Iowa researchers and their colleagues to develop a drinkable, carbon monoxide-infused foam that boosted the effectiveness of the therapy, known as autophagy inhibition, in mice and human cells. The findings were recently published in the journal…
A University of Iowa-led team of international neuroscientists have obtained the first direct recordings of the human brain in the minutes before and after a brain hub crucial for language meaning was surgically disconnected. The results reveal the importance of brain hubs in neural networks and the remarkable way in which the human brain attempts to compensate when a hub is lost, with immediacy…